Unknown

Dataset Information

0

Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats


ABSTRACT:

Background

Several chronic pain disorders, such as migraine and fibromyalgia, have an increased prevalence in the female population. The underlying mechanisms of this sex-biased prevalence have yet to be thoroughly documented, but could be related to endogenous differences in neuromodulators in pain networks, including the endocannabinoid system. The cellular endocannabinoid system comprises the endogenous lipid signals 2-AG (2-arachidonoylglycerol) and AEA (anandamide); the enzymes that synthesize and degrade them; and the cannabinoid receptors. The relative prevalence of different components of the endocannabinoid system in specific brain regions may alter responses to endogenous and exogenous ligands.

Methods

Brain tissue from naïve male and estrous staged female Sprague Dawley rats was harvested from V1M cortex, periaqueductal gray, trigeminal nerve, and trigeminal nucleus caudalis. Tissue was analyzed for relative levels of endocannabinoid enzymes, ligands, and receptors via mass spectrometry, unlabeled quantitative proteomic analysis, and immunohistochemistry.

Results

Mass spectrometry revealed significant differences in 2-AG and AEA concentrations between males and females, as well as between female estrous cycle stages. Specifically, 2-AG concentration was lower within female PAG as compared to male PAG (*p = 0.0077); female 2-AG concentration within the PAG did not demonstrate estrous stage dependence. Immunohistochemistry followed by proteomics confirmed the prevalence of 2-AG-endocannabinoid system enzymes in the female PAG.

Conclusions

Our results suggest that sex differences exist in the endocannabinoid system in two CNS regions relevant to cortical spreading depression (V1M cortex) and descending modulatory networks in pain/anxiety (PAG). These basal differences in endogenous endocannabinoid mechanisms may facilitate the development of chronic pain conditions and may also underlie sex differences in response to therapeutic intervention.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13293-021-00402-2.

SUBMITTER: Levine A 

PROVIDER: S-EPMC8577021 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9143158 | biostudies-literature
| S-EPMC7811247 | biostudies-literature
| PRJNA732723 | ENA
| PRJNA548844 | ENA
| S-EPMC8494264 | biostudies-literature
| S-EPMC4223040 | biostudies-literature
| S-EPMC8484742 | biostudies-literature
| S-EPMC5988506 | biostudies-literature
| S-EPMC7788136 | biostudies-literature
| S-EPMC3734196 | biostudies-literature